Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction

Background: Heart rate recovery (HRR) is a marker of vagal tone, which is a powerful predictor of mortality in patients with cardiovascular disease. Sacubitril/valsartan (S/V) is a treatment for heart failure with reduced ejection fraction (HFrEF), which impressively impacts cardiovascular outcome....

Descripción completa

Detalles Bibliográficos
Autores principales: Giallauria, Francesco, Vitale, Giuseppe, Pacileo, Mario, Di Lorenzo, Anna, Oliviero, Alessandro, Passaro, Francesco, Calce, Roberta, Parlato, Alessandro, Testa, Crescenzo, D’Ambrosio, Giuseppe, Romano, Giuseppe, Clemenza, Francesco, Sarullo, Silvia, Venturini, Elio, Gentile, Marco, Nugara, Cinzia, Iannuzzo, Gabriella, D’Andrea, Antonello, Vigorito, Carlo, Sarullo, Filippo M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356720/
https://www.ncbi.nlm.nih.gov/pubmed/32560431
http://dx.doi.org/10.3390/jcm9061897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356720/
https://www.ncbi.nlm.nih.gov/pubmed/32560431
http://dx.doi.org/10.3390/jcm9061897

Ejemplares similares